Abstract:We aimed to identify serum biomarkers that predict knee osteoarthritis (OA) before the appearance of radiographic abnormalities in a cohort of 200 women. As few as six serum peptides, corresponding to six proteins, reached AUC 77% probability to distinguish those who developed OA from age-matched individuals who did not develop OA up to 8 years later. Prediction based on these blood biomarkers was superior to traditional prediction based on age and BMI (AUC 51%) or knee pain (AUC 57%). These results identify a prolonged molecular derangement of joint tissue before the onset of radiographic OA abnormalities consistent with an unresolved acute phase response. Among all 24 protein biomarkers predicting incident knee OA, the majority (58%) also predicted knee OA progression, revealing the existence of a pathophysiological "OA continuum" based on considerable similarity in the molecular pathophysiology of the progression to incident OA and the progression of established OA.

What problem does this paper attempt to address?

The main problem this paper attempts to address is predicting the occurrence of knee osteoarthritis (OA) through serum biomarkers, especially before radiographic abnormalities appear. Specifically, the researchers aim to identify serum biomarkers that can predict the occurrence of knee osteoarthritis within 8 years before radiographic abnormalities appear. ### Main Problems: 1. **Early Prediction**: Researchers hope to predict the occurrence of knee osteoarthritis through serum biomarkers before radiographic abnormalities appear. 2. **Improving Prediction Accuracy**: Can serum biomarkers provide higher prediction accuracy compared to traditional methods based on age and body mass index (BMI) or knee pain? 3. **Molecular Pathophysiological Continuity**: Researchers also explore whether the molecular pathophysiological changes before the occurrence of knee osteoarthritis are similar to those in the progression of already diagnosed knee osteoarthritis, supporting the concept of the "OA continuum." ### Research Background: - Globally, the incidence of osteoarthritis has increased by 9% over the past 28 years. - Osteoarthritis imposes a significant social and economic burden. - Early prevention and intervention are considered key to reducing the burden of osteoarthritis. - Currently, most biomarker studies focus on patients with knee osteoarthritis who already have radiographic abnormalities, with fewer studies on early-stage prediction. ### Research Objectives: - Predict the occurrence of knee osteoarthritis within 8 years before radiographic abnormalities appear through serum proteomic biomarkers. - Evaluate the predictive performance of these biomarkers, particularly their superiority compared to traditional risk factors (such as age, BMI, and knee pain). - Explore the similarity between the molecular pathophysiological changes in early knee osteoarthritis and those in the progression of already diagnosed knee osteoarthritis. ### Methods: - Study Subjects: 200 middle-aged women from the UK, divided into 100 cases of knee osteoarthritis and 100 age- and BMI-matched controls. - Data Collection: Blood samples were collected in the 2nd and 6th years, and radiographic evaluation was conducted in the 10th year. - Analysis Methods: Serum peptides were quantified using targeted multiple reaction monitoring (MRM) mass spectrometry, combined with machine learning techniques to select the best predictors. ### Results: - Serum biomarkers can distinguish individuals who will develop knee osteoarthritis within the next 8 years with a probability of 77%. - The predictive performance of serum biomarkers is significantly higher compared to traditional risk factors (such as age and BMI). - Most biomarkers predicting the occurrence of knee osteoarthritis also predicted the progression of knee osteoarthritis, supporting the concept of the "OA continuum." ### Conclusion: - Serum biomarkers have high accuracy in predicting the occurrence of knee osteoarthritis, especially before radiographic abnormalities appear. - The discovery of these biomarkers helps in the early identification of high-risk individuals, providing the possibility for early prevention and intervention. - The study results support the similarity of molecular pathophysiological changes in early and progressive stages of knee osteoarthritis, further validating the concept of the "OA continuum."

An osteoarthritis pathophysiological continuum revealed by molecular biomarkers

Serum proteomic biomarkers diagnostic of knee osteoarthritis

Osteoarthritis Year in Review 2024: Molecular biomarkers of osteoarthritis

Insights into osteoarthritis progression revealed by analyses of both knee tibiofemoral compartments

A comprehensive analysis of biomarkers associated with synovitis and chondrocyte apoptosis in osteoarthritis

Diagnostic biomarkers in knee osteoarthritis: Based on bioinformatics and experimental verification in vivo and in vitro

From biochemical markers to molecular endotypes of osteoarthritis: a review on validated biomarkers

Identification of Biomarkers Associated with Diagnosis of Osteoarthritis Patients Based on Bioinformatics and Machine Learning

Identification and validation of BCL6 and VEGFA as biomarkers and ageing patterns correlating with immune infiltrates in OA progression

Value of biomarkers in osteoarthritis: current status and perspectives

Identification and Analysis of Blood Gene Expression Signature for Osteoarthritis with Advanced Feature Selection Methods

Blood and urine biomarkers for the diagnosis of early stages of knee osteoarthritis: A systematic review

Biomarkers in Painful Symptomatic Knee OA Demonstrate That MRI Assessed Joint Damage and Type II Collagen Degradation Products Are Linked to Disease Progression

Bioinformatics-Led Discovery of Osteoarthritis Biomarkers and Inflammatory Infiltrates

Identification of Diagnostic Biomarkers of Osteoarthritis Based on Multi-Chip Integrated Analysis and Machine Learning.

Single-cell transcriptome and crosstalk analysis reveals immune alterations and key pathways in the bone marrow of knee OA patients

Exploring the Association of Innate Immunity Biomarkers With MRI Features in Both Early and Late Stages Osteoarthritis

Deconvoluting synovial fluid molecular endotypes in knee osteoarthritis: primary results from the STEpUP OA Consortium

Molecular Classification of Knee Osteoarthritis

Prognostic model to predict the incidence of radiographic knee osteoarthritis

COL3A1 and MMP9 Serve as Potential Diagnostic Biomarkers of Osteoarthritis and Are Associated With Immune Cell Infiltration